Cargando…
Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer
BACKGROUND: Locoregional therapy is rarely the standard of care for De Novo stage IV breast cancer but usually used for palliation of symptoms. This retrospective study aimed to determine whether surgery or radiation would contribute to survival benefit for this group of patients by examining the su...
Autores principales: | Chen, Peng-Yu, Cheng, Skye Hung-Chun, Hung, Chen-Fang, Yu, Ben-Long, Chen, Chii-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320159/ https://www.ncbi.nlm.nih.gov/pubmed/25674416 http://dx.doi.org/10.1186/2193-1801-2-589 |
Ejemplares similares
-
Role of Locoregional Treatment in De Novo Stage IV Breast Cancer
por: Lee, Joanna S, et al.
Publicado: (2020) -
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
por: Merloni, Filippo, et al.
Publicado: (2023) -
LUMINOUS database: lumbar multifidus muscle segmentation from ultrasound images
por: Belasso, Clyde J., et al.
Publicado: (2020) -
An Eighteen-Gene Classifier Predicts Locoregional Recurrence in Post-Mastectomy Breast Cancer Patients
por: Cheng, Skye H., et al.
Publicado: (2016) -
Induction Chemotherapy Improved Long Term Outcomes in Stage IV Locoregional Advanced Nasopharyngeal Carcinoma
por: Wang, Yu-Wen, et al.
Publicado: (2020)